These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Non-homogeneous marking of distal colonic mucosa using Dolichos biflorus lectin. Rosenberg DW Cancer Lett; 1995 Nov; 98(1):33-7. PubMed ID: 8529203 [TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of azoxymethane-induced aberrant crypt foci in inbred mice. Delker DA; Wang QS; Papanikolaou A; Whiteley HE; Rosenberg DW Exp Mol Pathol; 1999 Feb; 65(3):141-9. PubMed ID: 10234360 [TBL] [Abstract][Full Text] [Related]
4. Tumor formation is correlated with expression of beta-catenin-accumulated crypts in azoxymethane-induced colon carcinogenesis in mice. Hata K; Yamada Y; Kuno T; Hirose Y; Hara A; Qiang SH; Mori H Cancer Sci; 2004 Apr; 95(4):316-20. PubMed ID: 15072589 [TBL] [Abstract][Full Text] [Related]
5. Induction of aberrant crypts in murine colon with varying sensitivity to colon carcinogenesis. Rosenberg DW; Liu Y Cancer Lett; 1995 Jun; 92(2):209-14. PubMed ID: 7600532 [TBL] [Abstract][Full Text] [Related]
6. Expression analysis of the group IIA secretory phospholipase A(2) in mice with differential susceptibility to azoxymethane-induced colon tumorigenesis. Papanikolaou A; Wang QS; Mulherkar R; Bolt A; Rosenberg DW Carcinogenesis; 2000 Feb; 21(2):133-8. PubMed ID: 10657948 [TBL] [Abstract][Full Text] [Related]
7. Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice. Suzuki R; Kohno H; Sugie S; Nakagama H; Tanaka T Carcinogenesis; 2006 Jan; 27(1):162-9. PubMed ID: 16081511 [TBL] [Abstract][Full Text] [Related]
8. Azoxymethane-induced colon tumors and aberrant crypt foci in mice of different genetic susceptibility. Papanikolaou A; Wang QS; Delker DA; Rosenberg DW Cancer Lett; 1998 Aug; 130(1-2):29-34. PubMed ID: 9751253 [TBL] [Abstract][Full Text] [Related]
9. Hemizygous mice for the angiotensin II type 2 receptor gene have attenuated susceptibility to azoxymethane-induced colon tumorigenesis. Takagi T; Nakano Y; Takekoshi S; Inagami T; Tamura M Carcinogenesis; 2002 Jul; 23(7):1235-41. PubMed ID: 12117783 [TBL] [Abstract][Full Text] [Related]
10. Strain-specific homeostatic responses during early stages of Azoxymethane-induced colon tumorigenesis in mice. Guda K; Marino JN; Jung Y; Crary K; Dong M; Rosenberg DW Int J Oncol; 2007 Oct; 31(4):837-42. PubMed ID: 17786315 [TBL] [Abstract][Full Text] [Related]
11. Initial levels of azoxymethane-induced DNA methyl adducts are not predictive of tumor susceptibility in inbred mice. Papanikolaou A; Shank RC; Delker DA; Povey A; Cooper DP; Rosenberg DW Toxicol Appl Pharmacol; 1998 May; 150(1):196-203. PubMed ID: 9630469 [TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate. Tanaka T; Kawabata K; Kakumoto M; Makita H; Matsunaga K; Mori H; Satoh K; Hara A; Murakami A; Koshimizu K; Ohigashi H Jpn J Cancer Res; 1997 Sep; 88(9):821-30. PubMed ID: 9369929 [TBL] [Abstract][Full Text] [Related]
13. Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis. Papanikolaou A; Wang QS; Papanikolaou D; Whiteley HE; Rosenberg DW Carcinogenesis; 2000 Aug; 21(8):1567-72. PubMed ID: 10910960 [TBL] [Abstract][Full Text] [Related]
14. Altered expression of cyclin D1 and cyclin-dependent kinase 4 in azoxymethane-induced mouse colon tumorigenesis. Wang QS; Papanikolaou A; Sabourin CL; Rosenberg DW Carcinogenesis; 1998 Nov; 19(11):2001-6. PubMed ID: 9855016 [TBL] [Abstract][Full Text] [Related]
15. Dose-dependent promoting effect of dextran sodium sulfate on mouse colon carcinogenesis initiated with azoxymethane. Suzuki R; Kohno H; Sugie S; Tanaka T Histol Histopathol; 2005 Apr; 20(2):483-92. PubMed ID: 15736053 [TBL] [Abstract][Full Text] [Related]
16. Azoxymethane is a genetic background-dependent colorectal tumor initiator and promoter in mice: effects of dose, route, and diet. Bissahoyo A; Pearsall RS; Hanlon K; Amann V; Hicks D; Godfrey VL; Threadgill DW Toxicol Sci; 2005 Dec; 88(2):340-5. PubMed ID: 16150884 [TBL] [Abstract][Full Text] [Related]
17. Lack of enhancing effects of degraded lambda-carrageenan on the development of beta-catenin-accumulated crypts in male DBA/2J mice initiated with azoxymethane. Hata K; Tanaka T; Kohno H; Suzuki R; Qiang SH; Kuno T; Hirose Y; Hara A; Mori H Cancer Lett; 2006 Jul; 238(1):69-75. PubMed ID: 16046055 [TBL] [Abstract][Full Text] [Related]
18. Aberrant crypt foci in the colonic mucosa of rats treated with a genotoxic and nongenotoxic colon carcinogen. Whiteley LO; Hudson L; Pretlow TP Toxicol Pathol; 1996; 24(6):681-9. PubMed ID: 8994294 [TBL] [Abstract][Full Text] [Related]
19. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane. Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579 [TBL] [Abstract][Full Text] [Related]
20. Enhancement by thyroxine of experimental carcinogenesis induced in rat colon by azoxymethane. Iishi H; Tatsuta M; Baba M; Okuda S; Taniguchi H Int J Cancer; 1992 Apr; 50(6):974-6. PubMed ID: 1555896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]